Cricket Finds Its Digital Home in Bangladesh

VEON’s Banglalink to Stream ICC Cricket on Toffee - Seite 2

Through its digital operators, VEON Group offers a variety of digital products and initiatives across entertainment, financial services, digital health and education. As of March 2024, VEON serves 110 million total monthly active users across its proprietary digital products and services such as Toffee, Tamasha, BeeTV, KyivstarTV,  Simosa, myBL, JazzCash, Simply, Izi, BeeCloud and Helsi.

About Toffee
Toffee is an operator-agnostic digital streaming platform launched by Banglalink in 2019. Toffee provides a superior viewing experience with its simple navigation and is available to everyone in Bangladesh. Toffee is app and web-based, available for Android smartphones, Android TVs, and iOS devices. With the highest number of national and international live television channels, Toffee regularly broadcasts global sporting events LIVE and also offers a large collection of video-on-demand and user-generated content for its viewers. For more information visit: https://toffeelive.com

About Banglalink
Banglalink is one of the leading digital communications service providers in Bangladesh, working to unlock new opportunities for its customers as they navigate the digital world. Driven by the vision of transforming lives through technology, Banglalink also strives to transform into a future-ready service provider capable of catering to the demands of the new digital era. It is a subsidiary of VEON Ltd - a Nasdaq and Euronext listed connectivity provider headquartered in the Netherlands. For more information visit: www.banglalink.net

About VEON
VEON is a digital operator that provides converged connectivity and digital services to nearly 160 million customers.  Operating across six countries that are home to more than 7% of the world’s population, VEON is transforming lives through technology-driven services that empower individuals and drive economic growth.  Headquartered in Amsterdam, VEON is listed on NASDAQ and Euronext. For more information visit: www.veon.com

Disclaimer 
This release contains “forward-looking statements”, as the phrase is defined in Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Forward-looking statements are not historical facts, and include statements relating to, among other things, VEON’s digital products, commercial plans and partnerships. Forward-looking statements are inherently subject to risks and uncertainties, many of which VEON cannot predict with accuracy and some of which VEON might not even anticipate. The forward-looking statements contained in this release speak only as of the date of this release. VEON does not undertake to publicly update, except as required by U.S. federal securities laws, any forward-looking statement to reflect events or circumstances after such dates or to reflect the occurrence of unanticipated events.